5.0
12 Mar 2026
Current employee, less than 1 year
London, England
Recommend
CEO approval
Business outlook
Pros
Interesting work with real clinical impact. The team is friendly and supportive, and you get good exposure to sequencing technologies and clinical validation projects. Because the team is small, you can take ownership of projects and contribute ideas.
Cons
As the company is growing, some processes and documentation are still developing. Priorities can sometimes change quickly and communication between teams could be clearer.